KZIA

NASDAQ HEALTHCARE

Kazia Therapeutics Ltd ADR

$7.87

$0.06 (+0.77%)

Live quote

52w: $4.86 – $17.40

Loading chart…

P/E Ratio—

P/B Ratio—

EV/EBITDA—

Debt/Equity—

ROE—

ROIC—

Revenue Growth—

Gross Margin—

Kazia Therapeutics Limited, a biotechnology company focused on oncology, develops anticancer drugs. The company is headquartered in Sydney, Australia.

Own KZIA? Track it here.

Create a free account to add KZIA to a portfolio and watch your P/L update in real time.

Custom screens, valuation models and backtesting are coming to Pro.

Create a free account